cog, if you held on to your VRX long enough you should have been able to get out at your $88 target...even hit the $90 I suggested was possible. Still felt it was a pure gamble but hopefully it paid off for you !
Imaginary projected peak sales of 2 unapproved products...LOL
What #$%$ analysis !
CLDX couldn't even get $75 in a buyout today !!!!!
Above said...I expect CLDX to be moving higher at some point in the reasonably near future
Surprised the PPS didn't do better.
Big sell-off from $17.45 intra-day peak.
Otherwise the data you cite sounds excellent....whats the FDA waiting for ????
Agree the next real news should be the Q1 area OA results although they will only be partial.
I guess we address then what value it adds.
Partnerships will be nice, elimination of the debt would be nice.
Yes but a very low float in SPHS.
They also don't have millions of shares waiting to sell and millions more in warrants waiting to convert and sell.
What do you think about this big SPHS news giving them a 49 million market cap today...still under CYTX's.
Lets see if SPHS management is smart and raise some money with this pop.
You may get lucky...maybe even close to $90 as a simple play but may voting against Ackman on this one. Pure gamble imho. Hope it works out for you.
History and cash levels says our history of 50 to 200 million market cap of the last year or two seems right until more clarity is achieved. The more recent lower end of this range highlights the uncertainties along with a faction that was basically invited in by previous management and greatly destroyed the valuation.
Fixing broken companies can be a long and messy process. 2016 a pivotal year imho. Even then, market cap may disappoint many until a true sales ramp materializes.
What do you think about another cash raise in 2016 ?
Seems a very real possibility to me.
*** they always have had nada trouble raising non-dilutive funding***
That's why there is 100 million shares out ? LOL
If you have given up then I guess you sold and booked your loss otherwise you must still have some shred of hope.
PPS doesn't get fixed until balance sheet is fixed and to some players that may include a sales ramp.
Its the same simple message discussed for years here. All we have witnessed to date is hedge funds running up and pushing down the PPS for their own personal profit. CYTX has a shot here with scleroderma and OA. We saw nice demand for the OA trial. Scleroderma demand is still unknown as they try to get US sites open for the phase 3.
Agree with shareholder_boar as well
Nick...this is basic stuff if you are investing in companies running trials.
There is a small penalty for everytime you take a peek at a on going trial.
The trial should be powered for this.